Uptake of invitations to a lung health check offering low-dose CT lung cancer screening among an ethnically and socioeconomically diverse population at risk of lung cancer in the UK (SUMMIT): a prospective, longitudinal cohort study.

[1]  A. Hackshaw,et al.  Telephone risk-based eligibility assessment for low-dose CT lung cancer screening , 2022, Thorax.

[2]  Alex A. T. Bui,et al.  Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality , 2021, JAMA network open.

[3]  M. Cabana,et al.  Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. , 2021, JAMA.

[4]  S. Shete,et al.  Examining lung cancer screening utilization with public-use data: Opportunities and challenges. , 2021, Preventive medicine.

[5]  R. Bhopal,et al.  Are there ethnic and religious variations in uptake of bowel cancer screening? A retrospective cohort study among 1.7 million people in Scotland , 2020, BMJ Open.

[6]  A. Nicholson,et al.  Baseline Results of the West London lung cancer screening pilot study - Impact of mobile scanners and dual risk model utilisation. , 2020, Lung cancer.

[7]  Adam W. Black,et al.  Area Deprivation Index and Rurality in Relation to Lung Cancer Prevalence and Mortality in a Rural State , 2020, JNCI cancer spectrum.

[8]  P. Mazzone,et al.  Lung Cancer Screening: Characteristics of Nonparticipants and Potential Screening Barriers. , 2020, Clinical lung cancer.

[9]  Harry J de Koning,et al.  Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. , 2020, The New England journal of medicine.

[10]  A. Bhowmik,et al.  Lung Screen Uptake Trial (LSUT): Randomised Controlled Trial Testing Targeted Invitation Materials. , 2019, American journal of respiratory and critical care medicine.

[11]  J. Eberth,et al.  Lung Cancer Screening Utilization: A Behavioral Risk Factor Surveillance System Analysis. , 2019, American journal of preventive medicine.

[12]  C. Berg,et al.  Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol. , 2019, The Lancet. Respiratory medicine.

[13]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[14]  A. Flahault,et al.  Participation in lung cancer screening programs: are there gender and social differences? A systematic review , 2018, Public Health Reviews.

[15]  C. von Wagner,et al.  Use of a GP-endorsed 12 months’ reminder letter to promote uptake of bowel scope screening: protocol for a randomised controlled trial in a hard-to-reach population , 2018, BMJ Open.

[16]  R. Booton,et al.  Implementing lung cancer screening: baseline results from a community-based ‘Lung Health Check’ pilot in deprived areas of Manchester , 2018, Thorax.

[17]  C. von Wagner,et al.  Use of Two Self-referral Reminders and a Theory-Based Leaflet to Increase the Uptake of Flexible Sigmoidoscopy in the English Bowel Scope Screening Program: Results From a Randomized Controlled Trial in London , 2018, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[18]  S. Lam,et al.  Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study. , 2017, The Lancet. Oncology.

[19]  S. Duffy,et al.  Effect of second timed appointments for non-attenders of breast cancer screening in England: a randomised controlled trial , 2017, The Lancet. Oncology.

[20]  S. Duffy,et al.  GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project , 2017, British Journal of Cancer.

[21]  S. Duffy,et al.  Rapid review of evaluation of interventions to improve participation in cancer screening services , 2016, Journal of medical screening.

[22]  J. Wardle,et al.  Attitudes towards lung cancer screening in socioeconomically deprived and heavy smoking communities: informing screening communication , 2016, Health expectations : an international journal of public participation in health care and health policy.

[23]  S. Lönnberg,et al.  Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention , 2016, BMJ Open.

[24]  M. Schabath,et al.  Racial and Ethnic Differences in the Epidemiology and Genomics of Lung Cancer. , 2016, Cancer control : journal of the Moffitt Cancer Center.

[25]  N J Wald,et al.  UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening , 2015, Thorax.

[26]  S. Duffy,et al.  Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial , 2015, BMJ Open.

[27]  Henrik Møller,et al.  Breast cancer screening uptake among women from different ethnic groups in London: a population-based cohort study , 2014, BMJ Open.

[28]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[29]  Denise R. Aberle,et al.  Baseline Characteristics of Participants in the Randomized National Lung Screening Trial , 2010, Journal of the National Cancer Institute.

[30]  O. Miettinen,et al.  Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.